Status: Not yet recruiting
Effect of Dietary Fiber Supplementation on Systemic Inflammation and Clinical Parameters in COPD: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent respiratory symptoms and systemic inflammation. Dietary fiber intake has been associated with beneficial effects on gut microbiota composition and systemic inflammatory markers. This study aims to evaluate the effects of dietary fiber supplementation on systemic inflammation and clinical parameters in patients with COPD through a randomized, double-blind, placebo-controlled trial.
Participants needed: 100
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Júnea Regina Pires DrewsUpdated: Oct 9, 2026Locations: 1
Eligibility criteria
Diagnosis of COPD with no exacerbation episodes in the last 3 months [+7]
End-stage COPD (GOLD stage 4) [+14]